We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$61M
AUM Growth
-$5.18M
Cap. Flow
-$9.62M
Cap. Flow %
-15.78%
Top 10 Hldgs %
40.21%
Holding
93
New
23
Increased
18
Reduced
20
Closed
29

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.7M
2
AMZN icon
Amazon
AMZN
+$1.55M
3
SCHW
Charles Schwab
SCHW
+$1.47M
4
BABA icon
Alibaba
BABA
+$1.38M
5
SYF icon
Synchrony
SYF
+$1.03M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.87M
2
UNH icon
UnitedHealth
UNH
+$2.81M
3
HCA icon
HCA Healthcare
HCA
+$2.53M
4
GILD icon
Gilead Sciences
GILD
+$2.26M
5
LLY icon
Eli Lilly
LLY
+$1.84M

Sector Composition

Rank Sector Weight
1 Healthcare 51.04%
2 Technology 8.38%
3 Industrials 7.42%
4 Financials 7.32%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
51
DexCom
DXCM
$32B
$344K 0.56%
+16,784
New +$349K
ZLTQ
52
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$333K 0.55%
11,672
+1,153
+11% +$36.4K
VYGR icon
53
Voyager Therapeutics
VYGR
$198M
$285K 0.47%
+14,384
New +$331K
MYOK
54
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$229K 0.38%
+15,603
New +$191K
DMTX
55
DELISTED
Dimension Therapeutics, Inc
DMTX
$196K 0.32%
+18,626
New +$236K
CLVS
56
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$193K 0.32%
+5,500
New +$355K
AMAG
57
DELISTED
AMAG Pharmaceuticals
AMAG
$189K 0.31%
+6,267
New +$202K
GILD icon
58
Gilead Sciences
GILD
$165B
$94K 0.15%
933
-21,750
-96% -$2.26M
CHRS icon
59
Coherus Oncology
CHRS
$196M
$91K 0.15%
3,966
-3,065
-44% -$78.9K
TEAM icon
60
Atlassian
TEAM
$37.8B
$49K 0.08%
+1,643
New +$46.8K
JUNO
61
DELISTED
Juno Therapeutics, Inc.
JUNO
$42K 0.07%
+953
New +$47.3K
RGNX icon
62
Regenxbio
RGNX
$708M
$41K 0.07%
2,466
– –
MXL icon
63
MaxLinear
MXL
$6.8B
$19K 0.03%
1,314
– –
ADAP
64
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-18,194
Closed -$218K
ALLY icon
65
Ally Financial
ALLY
$13.3B
– –
-37,920
Closed -$773K
BKNG icon
66
Booking.com
BKNG
$161B
– –
-18,975
Closed -$939K
DBVT
67
DBV Technologies
DBVT
$847M
– –
-620
Closed -$220K
EXP icon
68
Eagle Materials
EXP
$6.57B
– –
-9,683
Closed -$663K
GOOG icon
69
Alphabet (Google) Class C
GOOG
$4.32T
– –
-21,900
Closed -$699K
HUM icon
70
Humana
HUM
$46.2B
– –
-2,877
Closed -$515K
JD icon
71
JD.com
JD
$44.5B
– –
-27,960
Closed -$729K
LBTYK icon
72
Liberty Global Class C
LBTYK
$3.49B
– –
-12,955
Closed -$461K
LLY icon
73
Eli Lilly
LLY
$1.06T
– –
-21,964
Closed -$1.84M
MA icon
74
Mastercard
MA
$493B
– –
-8,259
Closed -$744K
MCK icon
75
CALL
McKesson
MCK
$101B
– –
-6,900
Closed -$1K
1 2
3
4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Partner Investment Management held 93 positions worth $61M, down 7.8% from $66.2M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Partner Investment Management withdrew a net $9.62M in Q4 2015, closing 29 positions and reducing 20 holdings. Its most notable exit was Pfizer, an estimated $2.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 61% a quarter earlier, followed by Technology and Industrials.

Against the trend, Partner Investment Management opened a new position in Alphabet (Google) Class A worth $1.79M.

  • Partner Investment Management's largest Q4 2015 buy was Alphabet (Google) Class A: 45,960 shares worth $1.79M.
  • Partner Investment Management added most to Bristol-Myers Squibb in Q4 2015, an estimated $944K increase.
  • Partner Investment Management's biggest Q4 2015 reduction was UnitedHealth, cutting an estimated $2.81M.
  • Partner Investment Management fully exited Pfizer in Q4 2015, selling an estimated $2.87M.
  • Partner Investment Management's ten largest holdings make up 40% of its $61M portfolio in Q4 2015.
  • Partner Investment Management opened 23 new positions and closed 29 in Q4 2015.
  • Partner Investment Management's portfolio value fell 7.8% quarter-over-quarter to $61M.

Based on Partner Investment Management's 13F filing for Q4 2015, filed 16 Feb 2016.